These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 33782286)
1. 18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer. Liu BL; Hong JJ; Tang K; Lin J; Zheng XW Clin Nucl Med; 2021 Jul; 46(7):e355-e357. PubMed ID: 33782286 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT. Ji X; Wang L; Lin J; Tang K Clin Nucl Med; 2022 Jan; 47(1):e74-e76. PubMed ID: 34238806 [TBL] [Abstract][Full Text] [Related]
4. 18F-PSMA 1007 Uptake in a Man With Metastatic Breast Cancer. Marafi F; Sasikumar A; Alfeeli M; Thuruthel S Clin Nucl Med; 2020 Jun; 45(6):e276-e278. PubMed ID: 32332302 [TBL] [Abstract][Full Text] [Related]
5. Biochemical Recurrence of Prostate Cancer: Initial Results with [ Giesel FL; Will L; Kesch C; Freitag M; Kremer C; Merkle J; Neels OC; Cardinale J; Hadaschik B; Hohenfellner M; Kopka K; Haberkorn U; Kratochwil C J Nucl Med; 2018 Apr; 59(4):632-635. PubMed ID: 29419475 [TBL] [Abstract][Full Text] [Related]
6. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT. Tang K; Wang Z; Lin J; Zheng X Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneous uptake of Hu Y; Wang P; Dai W BMC Pulm Med; 2023 Mar; 23(1):73. PubMed ID: 36882747 [TBL] [Abstract][Full Text] [Related]
8. 18F-PSMA 1007 Uptake in Brain Metastases From Breast Cancer. Marafi F; Sasikumar A; Alfeeli M; Fathallah W Clin Nucl Med; 2020 Feb; 45(2):e77-e79. PubMed ID: 31693624 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml. Witkowska-Patena E; Giżewska A; Dziuk M; Miśko J; Budzyńska A; Walęcka-Mazur A Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):343-348. PubMed ID: 31780781 [TBL] [Abstract][Full Text] [Related]
10. Incidental Finding of Colon Carcinoma Related to High Uptake in 18F-PSMA-1007 PET. Arçay A; Eiber M; Langbein T Clin Nucl Med; 2020 Jul; 45(7):561-562. PubMed ID: 32433166 [TBL] [Abstract][Full Text] [Related]
11. 18F-PSMA-1007 Uptake in Paget Disease of the Bone: An "Iron Man" Sign. Alfeeli M; Marafi F; Esmail A; Fathallah WMA; Usmani S Clin Nucl Med; 2022 Mar; 47(3):249-250. PubMed ID: 34392292 [TBL] [Abstract][Full Text] [Related]
19. Detection of Local Relapse of Prostate Cancer With 18F-PSMA-1007. Seifert R; Schafigh D; Bögemann M; Weckesser M; Rahbar K Clin Nucl Med; 2019 Jun; 44(6):e394-e395. PubMed ID: 30889005 [TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT. Zukotynski KA; Jadvar H; Potvin K; Cho SY; Kim CK; Winquist E Clin Nucl Med; 2020 Sep; 45(9):727-729. PubMed ID: 32520499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]